Formative—ALZA Annual Report:
ALZA, a drug technology and pharmaceutical company, develops and owns the technologies behind Nicoderm patches, time-released Sudafed, and hundreds of other products sold by pharmaceutical companies around the world. The company also develops and markets its own pharmaceutical products. We've designed annual reports and investor relations materials for ALZA since 1998. ALZA achieved record revenues of $988 million in FY 2000, and was acquired by Johnson & Johnson in 2001.